Type 2 diabetes is a chronic metabolic disease characterised by elevated levels of glucose in the blood, and presents a major and growing global public health challenge. While both genes […]
Researchers uncover genetic marker associated with fatty liver disease
The link between a specific genetic marker and severity of non-alcoholic fatty liver disease (NAFLD) has been validated in this study by researchers from several institutions and organisations, including the […]
MRC Epidemiology Unit launches study to monitor COVID-19 in 12,000 Cambridgeshire residents
Participants in Cambridgeshire’s Fenland Study are being invited to join an innovative study that will use a home-administered blood sampling device to find out how many have evidence in their […]
Study highlights potential for ‘liquid health check’ to predict disease risk
Proteins in our blood could in future help provide a comprehensive ‘liquid health check’, assessing our health and predicting the likelihood that we will we will develop a range of […]
Discovery of genetic variants that protect against obesity and type 2 diabetes could lead to new weight loss medicines
Around four million people in the UK carry genetic variants that protect them from obesity, type 2 diabetes and heart disease, suggests new research from the University of Cambridge. The […]
Circulating glycine is genetically associated with lower risk of coronary heart disease
A new cross-platform meta-analysis of genome-wide association studies for glycine in more than 80,000 participants, led by Dr Claudia Langenberg and PhD student Laura Wittemans of our Aetiology of Diabetes Programme, and published […]
Gene variations that reduce ability to store fat around the hips linked to higher risk of diabetes and heart attacks
People who are less likely to put on excess fat around their hips due to their genes are at higher risk of type 2 diabetes and heart attacks, according to […]
New drugs could reduce risk of heart disease and diabetes when added to statins, according to genetic study simulating clinical trial
New drugs that lower levels of triglycerides (a type of fat) in blood could further reduce the risk of heart attack when added to statins. These new drugs, which are […]
Helmholtz International Fellow Award for Dr Claudia Langenberg
Dr Claudia Langenberg, a Programme Leader with our Aetiology of Diabetes and Related Metabolic disorders programme, is one of five scientists to win this year’s Helmholtz International Fellow Award. This […]
How genetic studies are helping to explain the global surge of type 2 diabetes
Type 2 diabetes affects hundreds of millions of people worldwide and understanding its causes is essential to stem the rapid increase in the number of people affected by this chronic […]